United States Healthcare Providers & Services

US-China Biomedical Technology Inc (UCBB)

Track

Ticker: UCBB Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Huang Qingxi CEO, CFO, Secy., Treas. Executive Director Large shareholder
Transaction date
Purchase
Price
495.49
Quantity 57,603 -34.6%
Value US$3,940,166
Goldenrise Development, Inc. Large shareholder
Transaction date
Sale
Price
402.08
Quantity 96,017 +6.3%
Value US$1,249,406
Dunn Michael R CEO, CFO, President Executive Director Large shareholder
Transaction date
Purchase
Price
0.03
Quantity 3,500,000 +inf%
Value US$115,500
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
6.30
Quantity 250 +1.7%
Value US$1,575
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
8.00
Quantity 1,205 +9.1%
Value US$9,640
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
7.20
Quantity 230 +1.8%
Value US$1,656
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
3.50
Quantity 77 +0.6%
Value US$270
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
4.45
Quantity 3,273 +33.6%
Value US$14,565
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
4.45
Quantity 1,650 +20.4%
Value US$7,342
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
4.20
Quantity 4,900 +154.1%
Value US$20,580
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
4.15
Quantity 100 +3.2%
Value US$415
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
1.90
Quantity 520 +20.3%
Value US$988
Mu Zhen Secretary Executive Director
Transaction date
Purchase
Price
1.48
Quantity 1,000 +64.1%
Value US$1,480
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-07-05 2019-05-29 B Purchase
Huang Qingxi

CEO, CFO, Secy., Treas.

Executive Director Large shareholder
57,603 -34.6%
495.49
US$3,940,166 		57,603 -34.6% 495.49 US$3,940,166
2019-07-05 2019-05-29 B Purchase
China Israel Biotechnology Co. Ltd
Large shareholder
69,222 +14.0%
61.52
US$2,555,362 		69,222 +14.0% 61.52 US$2,555,362
2017-08-02 2017-07-28 S Sale Goldenrise Development, Inc. Large shareholder
96,017 +6.3%
402.08
US$1,249,406 		96,017 +6.3% 402.08 US$1,249,406
2017-08-02 2017-07-28 B Purchase Dunn Michael R

CEO, CFO, President

Executive Director Large shareholder
3,500,000 +inf%
0.03
US$115,500 		3,500,000 +inf% 0.03 US$115,500
2015-08-21 2015-08-03 B Purchase Mu Zhen

Secretary

Executive Director
250 +1.7%
6.30
US$1,575 		250 +1.7% 6.30 US$1,575
2015-08-21 2015-08-03 B Purchase Mu Zhen

Secretary

Executive Director
1,205 +9.1%
8.00
US$9,640 		1,205 +9.1% 8.00 US$9,640
2015-08-21 2015-08-03 B Purchase Mu Zhen

Secretary

Executive Director
230 +1.8%
7.20
US$1,656 		230 +1.8% 7.20 US$1,656
2015-08-21 2015-07-15 B Purchase Mu Zhen

Secretary

Executive Director
77 +0.6%
3.50
US$270 		77 +0.6% 3.50 US$270
2015-08-21 2015-07-14 B Purchase Mu Zhen

Secretary

Executive Director
3,273 +33.6%
4.45
US$14,565 		3,273 +33.6% 4.45 US$14,565
2015-08-21 2015-07-13 B Purchase Mu Zhen

Secretary

Executive Director
1,650 +20.4%
4.45
US$7,342 		1,650 +20.4% 4.45 US$7,342
2015-08-21 2015-07-10 B Purchase Mu Zhen

Secretary

Executive Director
4,900 +154.1%
4.20
US$20,580 		4,900 +154.1% 4.20 US$20,580
2015-08-21 2015-07-09 B Purchase Mu Zhen

Secretary

Executive Director
100 +3.2%
4.15
US$415 		100 +3.2% 4.15 US$415
2015-08-21 2015-06-23 B Purchase Mu Zhen

Secretary

Executive Director
520 +20.3%
1.90
US$988 		520 +20.3% 1.90 US$988
2015-08-21 2015-06-01 B Purchase Mu Zhen

Secretary

Executive Director
1,000 +64.1%
1.48
US$1,480 		1,000 +64.1% 1.48 US$1,480
Explore more

More insider trading research around US-China Biomedical Technology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America